Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012, International Journal of Cancer, vol.136, pp.359-386, 2015. ,
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape, Annals of Oncology, vol.27, 2004. ,
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomes, Therapeutic Advances in Medical Oncology, vol.8, pp.198-208, 2016. ,
The evolving role of pemetrexed (Alimta) in lung cancer, Seminars in Oncology, vol.32, pp.16-22, 2005. ,
Pharmacology and Mechanism of Action of Pemetrexed, Clinical Lung Cancer, vol.5, pp.51-55, 2004. ,
The Role of Pemetrexed (Alimta ® , LY231514) in Lung Cancer Therapy, Clinical Lung Cancer, vol.5, pp.21-27, 2003. ,
Microbiota: a key orchestrator of cancer therapy, Nature Reviews Cancer, vol.17, pp.271-285, 2017. ,
Cancer and the microbiota, Science, vol.348, pp.80-86, 2015. ,
Gut microbiome and anticancer immune response: really hot Sh*t!, Cell Death and Differentiation, vol.22, pp.199-214, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01204458
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme, Science, vol.330, pp.831-835, 2010. ,
FELASA Guidelines and Recommendations, Journal of the American Association for Laboratory Animal Science, vol.51, pp.311-321, 2012. ,
Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps, Cancer Medicine, vol.4, pp.201-211, 2015. ,
Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencingbased diversity studies, Nucleic acids research, vol.41, p.1, 2013. ,
, Scientific RepoRtS |, vol.10, p.9094, 2020.
Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities, Applied and environmental microbiology, vol.75, pp.7537-7578, 2009. ,
R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2015. ,
Intrauterine growth restriction not only modifies the cecocolonic microbiota in neonatal rats but also affects its activity in young adult rats, J. Pediatr. Gastroenterol. Nutr, vol.51, pp.402-413, 2010. ,
Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet-Induced Obesity and Diabetes in Mice, Diabetes, vol.57, pp.1470-1481, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00410066
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for, Inflammatory Bowel Diseases. Front. Immunol, vol.10, 2019. ,
Meta-analysis of gut microbiome studies identifies disease-specific and shared responses, Nat Commun, vol.8, p.1784, 2017. ,
Review article: the role of butyrate on colonic function: REVIEW: ROLE OF BUTYRATE ON COLONIC FUNCTION, Alimentary Pharmacology & Therapeutics, vol.27, pp.104-119, 2007. ,
Modulation of Gut Microbiome Composition and Function in Experimental Colitis Treated with Sulfasalazine, Frontiers in Microbiology, vol.8, 2017. ,
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers, ISME J, vol.6, pp.320-329, 2012. ,
The Intestinal Microbiota in Colorectal Cancer, Cancer Cell, vol.33, pp.954-964, 2018. ,
Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations, PLoS ONE, vol.11, p.152126, 2016. ,
Host-microbial Cross-talk in Inflammatory Bowel Disease, Immune Netw, vol.17, pp.1-12, 2017. ,
Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives, Microbiology, vol.156, pp.3205-3215, 2010. ,
Gut Microbiota and Predicted Metabolic Pathways in a Sample of Mexican Women Affected by Obesity and Obesity Plus Metabolic Syndrome, Int J Mol Sci, vol.20, 2019. ,
Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice, Microbes Environ, vol.29, pp.427-430, 2014. ,
Lachnospiraceae shift in the microbial community of mice faecal sample effects on water immersion restraint stress, AMB Express, vol.7, 2017. ,
Colonic inflammation accompanies an increase of ?-catenin signaling and Lachnospiraceae/Streptococcaceae bacteria in the hind gut of high-fat diet-fed mice, The Journal of Nutritional Biochemistry, vol.35, pp.30-36, 2016. ,
Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy, Mol. Cancer Ther, vol.1, pp.545-552, 2002. ,
Standing the test of time: targeting thymidylate biosynthesis in cancer therapy, Nature Reviews Clinical Oncology, vol.11, pp.282-298, 2014. ,
Factors Determining Colorectal Cancer: The Role of the Intestinal Microbiota, Frontiers in Oncology, vol.5, 2015. ,
Proteobacteria: microbial signature of dysbiosis in gut microbiota, Trends in Biotechnology, vol.33, pp.496-503, 2015. ,
16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation, Microb. Ecol, vol.67, pp.690-699, 2014. ,
IBD-what role do Proteobacteria play?, Nature Reviews Gastroenterology & Hepatology, vol.9, pp.219-230, 2012. ,
Microbial Respiration and Formate Oxidation as Metabolic Signatures of Inflammation-Associated Dysbiosis, Cell Host & Microbe, vol.21, pp.208-219, 2017. ,
Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis, Gut Microbes, vol.7, pp.414-423, 2016. ,
Mucin-bacterial interactions in the human oral cavity and digestive tract, Gut Microbes, vol.1, pp.254-268, 2010. ,
Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease, Nutrients, vol.8, p.44, 2016. ,
Resilience of the Dominant Human Fecal Microbiota upon Short-Course Antibiotic Challenge, Journal of Clinical Microbiology, vol.43, pp.5588-5592, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02682740
Humans as holobionts: implications for prevention and therapy, vol.6, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02625522